Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03114293

Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS — PIA  

Multiple Sclerosis, Chronic Progressive Clinical Trial

Official title:
Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS

Clinical Trial Summary

Due to their ubiquitary distribution, smartphones might serve as an easy way/ possibility to use feedback mechanism in an app-based intervention program to increase physical activity in Multiple Sclerosis (MS) patients. Internet based cognitive-behavioral interventions have been explored as effective in the last years. In addition, smartphone-based mobility assessment and intervention might be a promising approach in other MS types and for real-life mobility assessment in observational and interventional trials. The aim is to investigate the impact of a smartphone based information and feedback program on physical activity in a 3 months, randomised waiting-group controlled trial of 40 progressive MS patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03114293
Study type Interventional
Source Universitätsklinikum Hamburg-Eppendorf
Contact
Status Active, not recruiting
Phase N/A
Start date April 1, 2016
Completion date May 30, 2017
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Completed NCT01188811 - Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS) Phase 2/Phase 3
Recruiting NCT05562414 - Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis N/A
Completed NCT02545959 - Intrathecal Rituximab in Progressive Multiple Sclerosis Phase 2
Completed NCT01436838 - China Betaferon Adherence, Coping and Nurse Support Study N/A
Completed NCT03799718 - Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS Phase 2
Recruiting NCT00220493 - Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients Phase 1
Recruiting NCT05496881 - Exercise Effects in Multiple Sclerosis N/A
Recruiting NCT02903537 - Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS) Phase 1
Temporarily not available NCT02606929 - Use of Well Known Drugs for New Destination - MS Improvement (MSNT) Phase 0
Completed NCT03424538 - The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients N/A
Completed NCT02403570 - Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis
Active, not recruiting NCT04993274 - Sensitivity of Motor Assessment in MS - a Prospective Cohort Study
Active, not recruiting NCT00411723 - Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis Phase 1
Completed NCT00241254 - Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis Phase 3
Completed NCT02632591 - Use on Human Beings of Mix of Known Drugs for New Destination - MS Treatment Phase 1
Not yet recruiting NCT05385731 - MUSCLE - Nordic Walking in MUltiple SCLErosis N/A
Recruiting NCT05359653 - Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy Phase 1/Phase 2
Completed NCT04550650 - Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients N/A